GOTCHA: Optibiotix was forced to restate its accounts by the FRC thanks to the Sheriff of AIM

What folks like Laura “the cover up” Zelenko and crazy Meg Short at Bloomberg will never understand is that I am one of the good guys holding Companies to account. If I hang up my boots to become a goat farmer or when the grim reaper comes to pay a call, more folks will get away with financial crime or dodgy accounting because nobody else seems to raise issues with the regulators and force corrective action. Today I have received the letter below from the Financial Reporting Council regarding Optibiotix (OPTI).

Optibiotix Interims – get your cheque book ready Adam

Any loss making company reporting interims which gives the period end cash number but not also an up to date cash number hoists an enormous red flag and that brings us to Optibiotix (OPTI) which, ceteris paribus, will be running on vapours by early 2027. Half calendar year numbers are out today.

OptiBiotix Health (#OPTI) – H1 revenue +22%, though still just £0.68m and another loss

Optibiotix – here’s one it made earlier, and it wonders why nobody believes a word it says

Today Optibiotix (OPTI) has updated investors on progress of its Sweetbiotix product. Suffice to sat it is all sugar free jam tomorrow. In case you doubted that, I remind you of events back in September 2020, 6 years ago.

Optibiotix: Letter to the Financial Reporting Council

I got a generic email this morning from Optibiotix (OPTI) begging me to gp to the Sweetbiotix tasting and rampfest in London later thus month. It must be desperate. My guess is that, unless the venue is switched to an old fashioned telephone box, the event will not exactly be packed out.  These days most folks holdings are worth less than a Standard Class return to London so why bother to hear Lyin’ Steve O’Hara promise more jam tomorrow on a product where he  promised an imminent commercial launch almost a decade ago?  Meanwhile I have written to my good pals at the Financial Reporting Council about the litany of schoolboy errors in the 2025 accounts which emerged last week.

OptiBiotix Health (#OPTI) – “Investor presentation and SweetBiotix Sampling”, RNS Reach ramptastic

BREAKING EXPOSE: Optibiotix serves up wholesale accounting errors in regard to half a million quid of CEO pay

I have flagged up accounting errors at Optibiotix (OPTI) before and it has quietly made changes without acknowledging its historic blunders or thanking me. But the 2025 accounts out last week, the first produced by new FD David Blain, contain industrial scale errors which I shall be referring for the Financial Reporting Council. This is embarrassingly amateurish.

Optibiotix – Evil Says……

One of the great sayings of the great bear himself, Evil Knievil, was that an insignificant director share purchase is not a buy signal to the market, but a sell signal. And that brings me to the FD of AIM-listed Optibiotix (OPTI) which seems to me to be heading for a train crash as I disagree with independent auditor Gerald Edelman LLP over its passing of Optibiotix as a going concern.

OptiBiotix Health (#OPTI) – 2025 increased loss, cash £1m

Optibiotix, the material uncertainty – might a placing be on the cards? More dilution vicar?

I do not know but I speculate.  Optibiotix (OPTI) will publish its results for the year to December 31 at some point in June. History suggests that it will be at the end of the month.

Who do you think you are kidding Mr O’Hara?

It was, as I pointed out the other day, almost ten years ago that Police Time Wastin’Steve O’Hara of Optibiotix (OPTI) took to the media claiming that a commercial launch of Sweetbiotix was just around the corner. This time last year O’Hara was in detailed discussions with Pepsi or was it Coke. Who cares if it came to nowt but he got a share placement away.

Optibiotix: Tell me lies tell me sweetbiotix lies

I hope Fleetwood Mac fans get the title. In a posting on the Optibiotix (OPTI)  website last week, Police Time Wastin’ Steve O’Hara made claims about his cash runway which he cannot stand up and which the Oxymorons at AIM Regulation, at my behest, is now looking into. But he also made claims about Sweetbiotix. Police Time Wastin’ Steve said: it was “developing nicely” and that has excited some folks out there.

Optibiotix- has your Nomad approved this statement (which cannot be true)?

When, albeit in a misleading manner, Optibiotix (OPTI) announced that it had dumped most of its shares in Skinbiotherapeutics (SBTX), the family silver, its Nomad, Liam “the Toke” Murray signed off on an RNS saying that Optibiotix had enough working capital to last into H1 2027.. But…

OptiBiotix Health (#OPTI) – argues “strong period of growth and record start to 2026”, but 2025 another loss

Optibiotix – how about a FULL trading statement?

Shares in Optibiotix (OPTI) have fallen to just 5.85p, valuing the business at just £6 million. The lack of a full trading statement is now ringing alarm bells.

OptiBiotix Health (#OPTI) – “Statement: SkinBioTherapeutics”, states no “current” intention to sell its shares and no “current” requirement to raise new funds itself

Optibiotix Orders Announced – do I have sellers remorse?

It has been suggested elsewhere that I may have sellers regret with regard to both Optibiotix (OPTI) and Skinbiotherapeutics (SBTX). Since I put my disposal proceeds into Kefi and Amaroq, which have both raced ahead, I do not. Moreover I do not need to worry about management with a track record of bollocksing things up and of serving up incomplete trading statements. That brings me to today’s RNS from Optibiotix.

Optibiotix – I’m out

I should have sold a while back when it became abundantly clear that:

OptiBiotix Health (#OPTI) – after changes and delays, now “hopes to be in a position to demonstrate a range of SweetBiotix products to investors in H1 2026”

Letter to Liam Murray – another Optibiotix AGM statement needing correcting?

Clearly the big lie, and it was a blatant lie told to we loyal shareholders at the AGM of Optibiotix (OPTI) was, as heroic Ed from Islington called out on the day, Neil Davidson’s version of events leading up to the infamous made up RNS of October 10. But there is another statement made by the grossly overpaid chairman that also now needs correcting. I have written to Nomad, Liam “The Toke” Murray at Cairn Financial.